Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yamaç Tekintaş & Aybala Temel. (2024) Antisense oligonucleotides: a promising therapeutic option against infectious diseases. Nucleosides, Nucleotides & Nucleic Acids 43:1, pages 1-39.
Read now
Read now
Frederick Hansen, Heinz Feldmann & Michael A Jarvis. (2021) Targeting Ebola virus replication through pharmaceutical intervention. Expert Opinion on Investigational Drugs 30:3, pages 201-226.
Read now
Read now
Articles from other publishers (64)
Elena Kazakova, Thomas R. Lane, Thane Jones, Ana C. Puhl, Olga Riabova, Vadim Makarov & Sean Ekins. (2023)
1-Sulfonyl-3-amino-1
H
-1,2,4-triazoles as Yellow Fever Virus Inhibitors: Synthesis and Structure–Activity Relationship
. ACS Omega 8:45, pages 42951-42965.
Crossref
Crossref
Manizheh Avatefi Hemmat, Sahar Asghari, Mehran Bakhshesh & Matin Mahmoudifard. (2023) Copper iodide decorated graphene oxide as a highly efficient antibacterial and antiviral nanocomposite. Inorganic Chemistry Communications 156, pages 111214.
Crossref
Crossref
Vitor Won-Held Rabelo, Verônica Diniz da Silva, Maria Leonisa Sanchez Nuñez, Leonardo dos Santos Corrêa Amorim, Camilla Djenne Buarque, Richard J Kuhn, Paula Alvarez Abreu & Izabel Christina Nunes de Palmer Paixão. (2023) Antiviral evaluation of 1,4-disubstituted-1,2,3-triazole derivatives against Chikungunya virus. Future Virology 18:13, pages 865-880.
Crossref
Crossref
Łukasz Suprewicz, Artur Szczepański, Marzena Lenart, Ewelina Piktel, Krzysztof Fiedoruk, Emilia Barreto-Duran, Anna Kula-Pacurar, Paul B. Savage, Aleksandra Milewska, Robert Bucki & Krzysztof Pyrć. (2023) Ceragenins exhibit antiviral activity against SARS-CoV-2 by increasing the expression and release of type I interferons upon activation of the host's immune response. Antiviral Research 217, pages 105676.
Crossref
Crossref
Rohan Narayan, Mansi Sharma, Rajesh Yadav, Abhijith Biji, Oyahida Khatun, Sumandeep Kaur, Aditi Kanojia, Christy Margrat Joy, Raju Rajmani, Pallavi Raj Sharma, Sharumathi Jeyasankar, Priya Rani, Radha Krishan Shandil, Shridhar Narayanan, Durga Chilakalapudi Rao, Vijaya Satchidanandam, Saumitra Das, Rachit Agarwal & Shashank Tripathi. (2023) Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo. Cell Reports Medicine 4:8, pages 101127.
Crossref
Crossref
Nuno Taveira. (2023) Antivirals and Vaccines. International Journal of Molecular Sciences 24:12, pages 10315.
Crossref
Crossref
Kathryn L. Roche, Stacy Remiszewski, Matthew J. Todd, John L. KulpIIIIII, Liudi Tang, Alison V. Welsh, Ashley P. Barry, Chandrav De, William W. Reiley, Angela Wahl, J. Victor Garcia, Micah A. Luftig, Thomas Shenk, James R. Tonra, Eain A. Murphy & Lillian W. Chiang. (2023) An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity. Journal of Clinical Investigation 133:12.
Crossref
Crossref
Marwah Karim, Chieh-Wen Lo & Shirit Einav. (2023) Preparing for the next viral threat with broad-spectrum antivirals. Journal of Clinical Investigation 133:11.
Crossref
Crossref
Satoshi Kitaura, Minoru Tobiume, Madoka Kawahara, Masaaki Satoh, Hirofumi Kato, Noriko Nakayama, Nozomi Nakajima, Takashi Komeno, Yousuke Furuta, Tadaki Suzuki, Kyoji Moriya, Masayuki Saijo, Hideki Ebihara & Mutsuyo Takayama-Ito. (2023) Evaluation of a novel severe combined immunodeficiency mouse model for antiviral drug evaluation against Chandipura virus infection. Antiviral Research 213, pages 105582.
Crossref
Crossref
James P. Cerney, Aleksey Raskovalov, Monica Nasseri, Madeline D. Silva & Katherine D. McReynolds. (2023) Synthesis and Nuclear Magnetic Resonance Structural Evaluation of Oxime-Linked Oligosialic Acid-Based Glycodendrimers. Biomacromolecules 24:4, pages 1901-1911.
Crossref
Crossref
Asha Ripanda, Mwemezi J. Rwiza, Elias Charles Nyanza, Ramadhani Bakari, Hossein Miraji, Karoli N. Njau, Said Ali Hamad Vuai & Revocatus L. Machunda. (2023) Removal of lamivudine from synthetic solution using jamun seed (Syzygium cumini) biochar adsorbent. Emerging Contaminants, pages 100232.
Crossref
Crossref
Jacques Fantini, Henri Chahinian & Nouara Yahi. (2023) Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future. International Journal of Molecular Sciences 24:3, pages 1923.
Crossref
Crossref
Amal Kumar Dhara & Amit Kumar Nayak. 2023. Viral Infections and Antiviral Therapies. Viral Infections and Antiviral Therapies
3
22
.
Vuyolwethu Khwaza, Buhle Buyana, Xhamla Nqoro, Sijongesonke Peter, Zintle Mbese, Zizo Feketshane, Sibusiso Alven & Blessing A. Aderibigbe. 2023. Viral Infections and Antiviral Therapies. Viral Infections and Antiviral Therapies
407
492
.
Naila Safdar & Azra Yasmin. 2023. Synthesis of Bionanomaterials for Biomedical Applications. Synthesis of Bionanomaterials for Biomedical Applications
287
297
.
Nidhi Mishra, Neelu Singh & Poonam Parashar. 2023. Viral Drug Delivery Systems. Viral Drug Delivery Systems
119
139
.
Nishant Johri, Deepanshu Kumar, Priya Nagar, Aditya Maurya, Maheshwari Vengat & Parag Jain. (2022) Clinical manifestations of human monkeypox infection and implications for outbreak strategy. Health Sciences Review 5, pages 100055.
Crossref
Crossref
Massimo E. Maffei, Cristiano Salata & Giorgio Gribaudo. (2022) Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins. Molecules 27:23, pages 8353.
Crossref
Crossref
Sarah O'Keefe, Martin R. Pool & Stephen High. (2021) Membrane protein biogenesis at the ER: the highways and byways. The FEBS Journal 289:22, pages 6835-6862.
Crossref
Crossref
Giulia Sibille, Anna Luganini, Stefano Sainas, Donatella Boschi, Marco Lucio Lolli & Giorgio Gribaudo. (2022) The Novel hDHODH Inhibitor MEDS433 Prevents Influenza Virus Replication by Blocking Pyrimidine Biosynthesis. Viruses 14:10, pages 2281.
Crossref
Crossref
Mackingsley Kushan Dassanayake, Teng-Jin Khoo, Chien Hwa Chong & Patrick Di Martino. (2022) Molecular Docking and In-Silico Analysis of Natural Biomolecules against Dengue, Ebola, Zika, SARS-CoV-2 Variants of Concern and Monkeypox Virus. International Journal of Molecular Sciences 23:19, pages 11131.
Crossref
Crossref
Elaheh K. Goharshadi, Kimiya Goharshadi & Marjan Moghayedi. (2022) The use of nanotechnology in the fight against viruses: A critical review. Coordination Chemistry Reviews 464, pages 214559.
Crossref
Crossref
Aleksandr Ianevski, Ronja M Simonsen, Vegard Myhre, Tanel Tenson, Valentyn Oksenych, Magnar Bjørås & Denis E Kainov. (2022) DrugVirus.info 2.0: an integrative data portal for broad-spectrum antivirals (BSA) and BSA-containing drug combinations (BCCs). Nucleic Acids Research 50:W1, pages W272-W275.
Crossref
Crossref
Md. Mominur Rahman, Md. Rezaul Islam, Sheikh Shohag, Md. Emon Hossain, Muddaser Shah, Shakil khan shuvo, Hosneara Khan, Md. Arifur Rahman Chowdhury, Israt Jahan Bulbul, Md. Sarowar Hossain, Sharifa Sultana, Muniruddin Ahmed, Muhammad Furqan Akhtar, Ammara Saleem & Md. Habibur Rahman. (2022) Multifaceted role of natural sources for COVID-19 pandemic as marine drugs. Environmental Science and Pollution Research 29:31, pages 46527-46550.
Crossref
Crossref
Abhinandan Kumar, Vatika Soni, Pardeep Singh, Aftab Aslam Parwaz Khan, Mohammed Nazim, Satyabrata Mohapatra, Vipin Saini, Pankaj Raizada, Chaudhery Mustansar Hussain, Mohamed Shaban, Hadi M. Marwani & Abdullah M. Asiri. (2022) Green aspects of photocatalysts during corona pandemic: a promising role for the deactivation of COVID-19 virus. RSC Advances 12:22, pages 13609-13627.
Crossref
Crossref
Yucheng Zheng, Shiliang Li, Kun Song, Jiajie Ye, Wenkang Li, Yifan Zhong, Ziyan Feng, Simeng Liang, Zeng Cai & Ke Xu. (2022) A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses. Viruses 14:5, pages 928.
Crossref
Crossref
Lorenzo Botta, Silvia Cesarini, Claudio Zippilli, Bruno Mattia Bizzarri, Angelica Fanelli & Raffaele Saladino. (2022) Multicomponent Reactions in the Synthesis of Antiviral Compounds. Current Medicinal Chemistry 29:12, pages 2013-2050.
Crossref
Crossref
Goverdhan Mehta, Sarah E. Cornell, Alain Krief, Henning Hopf & Stephen A. Matlin. (2022) A shared future: chemistry's engagement is essential for resilience of people and planet. Royal Society Open Science 9:4.
Crossref
Crossref
Sajad Najafi, Shing Cheng Tan, Shahin Aghamiri, Pourya Raee, Zahra Ebrahimi, Zahra Kargar Jahromi, Yazdan Rahmati, Javid Sadri Nahand, Ahmad Piroozmand, Vahid Jajarmi & Hamed Mirzaei. (2022) Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections. Biomedicine & Pharmacotherapy 148, pages 112743.
Crossref
Crossref
Agnese Bregnocchi, Reza Jafari & Gelareh Momen. (2022) Design strategies for antiviral coatings and surfaces: A review. Applied Surface Science Advances 8, pages 100224.
Crossref
Crossref
Muzahidul I. Anik, Niaz Mahmud, Abdullah Al Masud & Maruf Hasan. (2021) Gold nanoparticles (GNPs) in biomedical and clinical applications: A review. Nano Select 3:4, pages 792-828.
Crossref
Crossref
Fabian Philipp Kreutzer, Anna Meinecke, Kevin Schmidt, Jan Fiedler & Thomas Thum. (2022) Alternative strategies in cardiac preclinical research and new clinical trial formats. Cardiovascular Research 118:3, pages 746-762.
Crossref
Crossref
Jonathan Ardhianto Panggabean, Sya’ban Putra Adiguna, Siti Irma Rahmawati, Peni Ahmadi, Elmi Nurhaidah Zainuddin, Asep Bayu & Masteria Yunovilsa Putra. (2022) Antiviral Activities of Algal-Based Sulfated Polysaccharides. Molecules 27:4, pages 1178.
Crossref
Crossref
Javier García-Cárceles, Elena Caballero, Carmen Gil & Ana Martínez. (2021) Kinase Inhibitors as Underexplored Antiviral Agents. Journal of Medicinal Chemistry 65:2, pages 935-954.
Crossref
Crossref
Gustavo R. Perez-Lemus, Cintia A. Menéndez, Walter Alvarado, Fabian Byléhn & Juan J. de Pablo. (2022) Toward wide-spectrum antivirals against coronaviruses: Molecular characterization of SARS-CoV-2 NSP13 helicase inhibitors. Science Advances 8:1.
Crossref
Crossref
Parth Chaturvedi, Payam Kelich, Tara A. Nitka & Lela Vuković. (2021) Computational Modeling of the Virucidal Inhibition Mechanism for Broad-Spectrum Antiviral Nanoparticles and HPV16 Capsid Segments. The Journal of Physical Chemistry B 125:48, pages 13122-13131.
Crossref
Crossref
Saurabh Shah, Mahavir Bhupal Chougule, Arun K. Kotha, Rama Kashikar, Chandraiah Godugu, Rajeev Singh Raghuvanshi, Shashi Bala Singh & Saurabh Srivastava. (2021) Nanomedicine based approaches for combating viral infections. Journal of Controlled Release 338, pages 80-104.
Crossref
Crossref
Carme Zambrana, Alexandros Xenos, René Böttcher, Noël Malod-Dognin & Nataša Pržulj. (2021) Network neighbors of viral targets and differentially expressed genes in COVID-19 are drug target candidates. Scientific Reports 11:1.
Crossref
Crossref
Victor O. Gawriljuk, Daniel H. Foil, Ana C. Puhl, Kimberley M. Zorn, Thomas R. Lane, Olga Riabova, Vadim Makarov, Andre S. Godoy, Glaucius Oliva & Sean Ekins. (2021) Development of Machine Learning Models and the Discovery of a New Antiviral Compound against Yellow Fever Virus. Journal of Chemical Information and Modeling 61:8, pages 3804-3813.
Crossref
Crossref
Arianna Calistri, Anna Luganini, Barbara Mognetti, Elizabeth Elder, Giulia Sibille, Valeria Conciatori, Claudia Del Vecchio, Stefano Sainas, Donatella Boschi, Nuria Montserrat, Ali Mirazimi, Marco Lucio Lolli, Giorgio Gribaudo & Cristina Parolin. (2021) The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses. Microorganisms 9:8, pages 1731.
Crossref
Crossref
Axel Hollmann, Nancy P. Cardoso, Juan C. Espeche & Paulo C. Maffía. (2021) Review of antiviral peptides for use against zoonotic and selected non-zoonotic viruses. Peptides 142, pages 170570.
Crossref
Crossref
Raphael E. F. Paiva, Erica J. Peterson, Jaroslav Malina, Mary Zoepfl, J. David Hampton, Wyatt E. Johnson, Angelica Graminha, Amine Ourahmane, Michael A. McVoy, Viktor Brabec, Susan J. Berners‐Price & Nicholas P. Farrell. (2021) On the Biology of Werner's Complex. Angewandte Chemie International Edition 60:31, pages 17123-17130.
Crossref
Crossref
Raphael E. F. Paiva, Erica J. Peterson, Jaroslav Malina, Mary Zoepfl, J. David Hampton, Wyatt E. Johnson, Angelica Graminha, Amine Ourahmane, Michael A. McVoy, Viktor Brabec, Susan J. Berners‐Price & Nicholas P. Farrell. (2021) On the Biology of Werner's Complex. Angewandte Chemie 133:31, pages 17260-17267.
Crossref
Crossref
James M. Wood, Gary B. Evans, Tyler L. Grove, Steven C. Almo, Scott A. Cameron, Richard H. Furneaux & Lawrence D. Harris. (2021) Chemical Synthesis of the Antiviral Nucleotide Analogue ddhCTP. The Journal of Organic Chemistry 86:13, pages 8843-8850.
Crossref
Crossref
Sofi Imtiyaz Ali, Wajid Mohammad Sheikh, Muzafar Ahmad Rather, Venugopalan Venkatesalu, Showkeen Muzamil Bashir & Showkat Ul Nabi. (2021) Medicinal plants: Treasure for antiviral drug discovery. Phytotherapy Research 35:7, pages 3447-3483.
Crossref
Crossref
Hanna Harant, Siegfried Höfinger, Franz Kricek, Christine Ruf, Zsolt Ruzsics, Hartmut Hengel & Ivan Lindley. (2021) The Peptide TAT-I24 with Antiviral Activity against DNA Viruses Binds Double-Stranded DNA with High Affinity. Biologics 1:1, pages 41-60.
Crossref
Crossref
Prasanta K. Dash, Santhi Gorantla, Larisa Poluektova, Mahmudul Hasan, Emiko Waight, Chen Zhang, Milica Markovic, Benson Edagwa, Jatin Machhi, Katherine E. Olson, Xinglong Wang, R. Lee Mosley, Bhavesh Kevadiya & Howard E. Gendelman. (2021) Humanized Mice for Infectious and Neurodegenerative disorders. Retrovirology 18:1.
Crossref
Crossref
Malobika Chakravarty & Amisha Vora. (2020) Nanotechnology-based antiviral therapeutics. Drug Delivery and Translational Research 11:3, pages 748-787.
Crossref
Crossref
Dengke Tian, Yuzhi Liu, Chengyuan Liang, Liang Xin, Xiaolin Xie, Dezhu Zhang, Minge Wan, Han Li, Xueqi Fu, Hong Liu & Wenqiang Cao. (2021) An update review of emerging small-molecule therapeutic options for COVID-19. Biomedicine & Pharmacotherapy 137, pages 111313.
Crossref
Crossref
Gaspar Taroncher-Oldenburg, Christin Müller, Wiebke Obermann, John Ziebuhr, Roland K. Hartmann & Arnold Grünweller. (2021) Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates—A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics. Microorganisms 9:3, pages 540.
Crossref
Crossref
Abhinav Saxena, Deepak Khare, Swati Agrawal, Angaraj Singh & Ashutosh Kumar Dubey. (2021) Recent advances in materials science: a reinforced approach toward challenges against COVID-19. Emergent Materials 4:1, pages 57-73.
Crossref
Crossref
Philip M. Bath, Christopher M. Coleman, Adam L. Gordon, Wei Shen Lim & Andrew J. Webb. (2021) Nitric oxide for the prevention and treatment of viral, bacterial, protozoal and fungal infections. F1000Research 10, pages 536.
Crossref
Crossref
Kieran Maheden, Brendan Todd, Calvin J. Gordon, Egor P. Tchesnokov & Matthias Götte. 2021. Viral Replication Enzymes and their Inhibitors Part A. Viral Replication Enzymes and their Inhibitors Part A
315
354
.
Yasmin Abo-zeid, Gareth R. Williams, Lila Touabi & Gary R. McLean. (2020) An investigation of rhinovirus infection on cellular uptake of poly (glycerol-adipate) nanoparticles. International Journal of Pharmaceutics 589, pages 119826.
Crossref
Crossref
Michał Otręba, Leon Kośmider & Anna Rzepecka-Stojko. (2020) Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review. European Journal of Pharmacology 887, pages 173553.
Crossref
Crossref
J Mukhopadhyay. (2020) The wicked game: COVID-19. The Journal of Community Health Management 7:3, pages 80-82.
Crossref
Crossref
Sophie L. Penman, Robyn T. Kiy, Rebecca L. Jensen, Christopher Beoku‐Betts, Ana Alfirevic, David Back, Saye H. Khoo, Andrew Owen, Munir Pirmohamed, B. Kevin Park, Xiaoli Meng, Christopher E. Goldring & Amy E. Chadwick. (2020) Safety perspectives on presently considered drugs for the treatment of COVID‐19. British Journal of Pharmacology 177:19, pages 4353-4374.
Crossref
Crossref
Ya-Wen Cheng, Tai-Ling Chao, Chiao-Ling Li, Mu-Fan Chiu, Han-Chieh Kao, Sheng-Han Wang, Yu-Hao Pang, Chih-Hui Lin, Ya-Min Tsai, Wen-Hau Lee, Mi-Hua Tao, Tung-Ching Ho, Ping-Yi Wu, Li-Ting Jang, Pei-Jer Chen, Sui-Yuan Chang & Shiou-Hwei Yeh. (2020) Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects. Cell Reports 33:2, pages 108254.
Crossref
Crossref
Rui Xiong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Yong Wang, Yongliang Zhao, Yan Wu, Weijuan Shang, Xiaming Jiang, Jiwei Shan, Zihao Shen, Yi Tong, Liuxin Xu, Yu Chen, Yingle Liu, Gang Zou, Dimitri Lavillete, Zhenjiang Zhao, Rui Wang, Lili Zhu, Gengfu Xiao, Ke Lan, Honglin Li & Ke Xu. (2020) Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Protein & Cell 11:10, pages 723-739.
Crossref
Crossref
Anastasiia I. Petushkova & Andrey A. ZamyatninJr.Jr.. (2020) Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations. Pharmaceuticals 13:10, pages 277.
Crossref
Crossref
Jia-bo Wang, Zhong-xia Wang, Jing Jing, Peng Zhao, Jing-hui Dong, Yong-feng Zhou, Guang Yang, Ming Niu, Xu Zhao, Tian-jun Jiang, Jing-feng Bi, Zhe Xu, Ping Zhang, Dan Wu, Zhao-fang Bai, Yu-ming Guo, Si-miao Yu, Yong-qiang Sun, Zi-teng Zhang, Xiao-yan Zhan, Peng-yan Li, Jin-biao Ding, Peng-fei Zhao, Xue-ai Song, Jian-yuan Tang, Dong-chu He, Zhu Chen, En-qiang Qin, Rui-lin Wang & Xiao-he Xiao. (2020) Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial. Chinese Journal of Integrative Medicine 26:9, pages 648-655.
Crossref
Crossref
Dongrong Yi, Quanjie Li, Lili Pang, Yujia Wang, Yongxin Zhang, Zhaojun Duan, Chen Liang & Shan Cen. (2020) Identification of a Broad-Spectrum Viral Inhibitor Targeting a Novel Allosteric Site in the RNA-Dependent RNA Polymerases of Dengue Virus and Norovirus. Frontiers in Microbiology 11.
Crossref
Crossref
Qianyu Lin, Jason Y. C. Lim, Kun Xue, Pek Yin Michelle Yew, Cally Owh, Pei Lin Chee & Xian Jun Loh. (2020) Sanitizing agents for virus inactivation and disinfection. VIEW 1:2.
Crossref
Crossref
Sabina W. Jaros, Jarosław Król, Barbara Bażanów, Dominik Poradowski, Aleksander Chrószcz, Dmytro S. Nesterov, Alexander M. Kirillov & Piotr Smoleński. (2020) Antiviral, Antibacterial, Antifungal, and Cytotoxic Silver(I) BioMOF Assembled from 1,3,5-Triaza-7-Phoshaadamantane and Pyromellitic Acid. Molecules 25:9, pages 2119.
Crossref
Crossref